RI
ALXN

Redwood Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Redwood Investments’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,889
Closed -$1.54M – 189
2015
Q1 		$1.54M Sell
8,889
-14,058
-61% -$2.54M 0.25% 82
2014
Q4 		$4.25M Sell
22,947
-6,987
-23% -$1.29M 0.64% 54
2014
Q3 		$4.96M Hold
29,934
– – 0.66% 50
2014
Q2 		$4.68M Sell
29,934
-22,268
-43% -$3.52M 0.58% 57
2014
Q1 		$7.94M Sell
52,202
-14,810
-22% -$2.35M 1.14% 36
2013
Q4 		$8.9M Hold
67,012
– – 1.33% 32
2013
Q3 		$7.78M Buy
67,012
+15,397
+30% +$1.69M 1.1% 41
2013
Q2 		$4.76M Buy
+51,615
New +$4.97M 0.73% 55

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Redwood Investments's ALXN Position: Q2 2015 in Review

Redwood Investments sold out of Alexion Pharmaceuticals (ALXN) in Q2 2015, closing a stake of 8,889 shares — an estimated $1.54M sold.

Redwood Investments first reported a position in ALXN in Q2 2013 and held it in 8 quarters. The position peaked at $8.9M in Q4 2013. 548 funds tracked by Wall St. Rank hold ALXN as of Q2 2015.

  • Redwood Investments reported no remaining Alexion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Redwood Investments sold 8,889 Alexion Pharmaceuticals shares in Q2 2015, an estimated $1.54M.
  • Redwood Investments first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • Redwood Investments's Alexion Pharmaceuticals position peaked at $8.9M in Q4 2013.
  • 548 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2015.

Based on Redwood Investments's 13F filing for Q2 2015, filed 31 Jul 2015.